Endocrine Today Current Issue
The following articles appeared in the print edition of Endocrine Today.
Table of Contents
- Referrals for early puberty increasing, but number of actual cases remains low
-
- Discovery of parathyroid fluorescence may reduce endocrine surgery risks
- Early metformin therapy delayed onset, prevention of PCOS
- FDA panel advises against approval of dapagliflozin
- New guidelines outline diagnosis, management of hyperthyroidism
- Report reveals ‘immense burden’ of osteoporotic fractures in Europe
- The pace of medical innovation Alan J. Garber, MD, PhD, MACE
- Hypertension in the elderly
- FDA seeks public input on medical mobile app oversight project
-
- Incidental hypermetabolic, FDG-avid thyroid nodule on a PET scan Stephanie L. Lee, MD, PhD, ECNU
- Copy-and-paste notes in EMRs detrimental to patients with diabetes
- IGF-I linked to long-term stroke recovery
- Insomnia, high insulin resistance linked
- ADDITION-Europe: Diabetes screening, early intensive intervention improved CV outcomes
- Early parenteral nutrition in critically ill patients should be delayed
- Lifestyle intervention, metformin eased financial burden of diabetes in DPP
- Novel therapies for type 2 diabetes on the horizon
-
- Older age not main cause of testosterone decline in healthy men
- RISE, RIDE: Ranibizumab bested sham injection in diabetic macular edema
- Selective GPR40 agonist safe, effective in type 2 diabetes
- Studies suggest teplizumab may be beneficial treatment for type 1 diabetes
- Testosterone has protective effect on memory in postmenopausal women
- Vaccine failed to slow progression of type 1 diabetes
- Linagliptin: A new DPP-IV inhibitor James R. Taylor, PharmD, CDE